Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Pregabalin capsules 150 mg of Dexa Medica

Each capsule contains 150 mg of pregabalin. Test product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

DRUG

Pregabalin capsules 150 mg of Pfizer Manufacturing Deutschland

Each capsule contains 150 mg of pregabalin. Reference product was given as a single dose, under the procedure as described in the Section: Detailed description of the study.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT02233777 - Bioequivalence Study of Two Formulations of Pregabalin Capsules 150 mg | Biotech Hunter | Biotech Hunter